Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 3296294, 10 pages
https://doi.org/10.1155/2017/3296294
Review Article

Sestrin2 as a Novel Biomarker and Therapeutic Target for Various Diseases

1College of Pharmacy, Qatar University, P.O. Box 2713, Doha, Qatar
2Department of Pharmacology and Toxicology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
3Department of Biological and Environmental Sciences, College of Arts and Sciences, Qatar University, P.O. Box 2713, Doha, Qatar
4Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
5School of Medicine, University of Texas Health Sciences Center at San Antonio, San Antonio, TX, USA

Correspondence should be addressed to Shankar Munusamy; aq.ude.uq@ymasunum.raknahs

Received 4 March 2017; Accepted 3 May 2017; Published 11 June 2017

Academic Editor: Alexander N. Orekhov

Copyright © 2017 Mazhar Pasha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Lee, A. V. Budanov, and M. Karin, “Sestrins orchestrate cellular metabolism to attenuate aging,” Cell Metabolism, vol. 18, no. 6, pp. 792–801, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Tsilioni, A. S. Filippidis, T. Kerenidi, A. V. Budanov, S. G. Zarogiannis, and K. I. Gourgoulianis, “Sestrin-2 is significantly increased in malignant pleural effusions due to lung cancer and is potentially secreted by pleural mesothelial cells,” Clinical Biochemistry, vol. 49, no. 9, pp. 726–728, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. A. V. Budanov, “Stress-responsive sestrins link p53 with redox regulation and mammalian target of rapamycin signaling,” Antioxidants & Redox Signaling, vol. 15, no. 6, pp. 1679–1690, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Seo, S. Seo, S. H. Ki, and S. M. Shin, “Sestrin2 inhibits hypoxia-inducible factor-1alpha accumulation via AMPK-mediated prolyl hydroxylase regulation,” Free Radical Biology & Medicine, vol. 101, pp. 511–523, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. A. V. Budanov, A. A. Sablina, E. Feinstein, E. V. Koonin, and P. M. Chumakov, “Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD,” Science, vol. 304, no. 5670, pp. 596–600, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. C. C. Chen, S. M. Jeon, P. T. Bhaskar et al., “FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor,” Developmental Cell, vol. 18, no. 4, pp. 592–604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. H. Bae, S. H. Sung, S. Y. Oh et al., “Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage,” Cell Metabolism, vol. 17, no. 1, pp. 73–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Morrison, L. Chen, J. Wang et al., “Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart,” The FASEB Journal, vol. 29, no. 2, pp. 408–417, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. A. V. Budanov and M. Karin, “p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling,” Cell, vol. 134, no. 3, pp. 451–460, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Y. Zhang, X. Q. Wu, R. Deng, T. Sun, G. K. Feng, and X. F. Zhu, “Upregulation of sestrin 2 expression via JNK pathway activation contributes to autophagy induction in cancer cells,” Cellular Signalling, vol. 25, no. 1, pp. 150–158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Ding, A. Parmigiani, C. Yang, and A. V. Budanov, “Sestrin2 facilitates death receptor-induced apoptosis in lung adenocarcinoma cells through regulation of XIAP degradation,” Cell Cycle, vol. 14, no. 20, pp. 3231–3241, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. K. B. Chen, Y. Xuan, W. J. Shi, F. Chi, R. Xing, and Y. C. Zeng, “Sestrin2 expression is a favorable prognostic factor in patients with non-small cell lung cancer,” American Journal of Translational Research, vol. 8, no. 4, pp. 1903–1909, 2016. View at Google Scholar
  13. N. Wang, W. Pan, M. Zhu et al., “Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells,” British Journal of Pharmacology, vol. 164, no. 2b, pp. 731–742, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Sun, R. Xue, F. Yao et al., “The critical role of Sestrin 1 in regulating the proliferation of cardiac fibroblasts,” Archives of Biochemistry and Biophysics, vol. 542, pp. 1–6, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. H. H. Liao, J. Y. Ruan, H. J. Liu, Y. Liu, H. Feng, and Q. Z. Tang, “Sestrin family may play important roles in the regulation of cardiac pathophysiology,” International Journal of Cardiology, vol. 202, pp. 183-184, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Xue, J. Zeng, Y. Chen et al., “Sestrin 1 ameliorates cardiac hypertrophy via autophagy activation,” Journal of Cellular and Molecular Medicine, vol. 21, no. 6, pp. 1193–1205, 2017. View at Publisher · View at Google Scholar
  17. X. Shi, D. M. Doycheva, L. Xu, J. Tang, M. Yan, and J. H. Zhang, “Sestrin2 induced by hypoxia inducible factor1 alpha protects the blood-brain barrier via inhibiting VEGF after severe hypoxic-ischemic injury in neonatal rats,” Neurobiology of Disease, vol. 95, pp. 111–121, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. A. V. Budanov, J. H. Lee, and M. Karin, “Stressin’ Sestrins take an aging fight,” EMBO Molecular Medicine, vol. 2, no. 10, pp. 388–400, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. S. Hou, J. J. Guan, H. D. Xu, F. Wu, R. Sheng, and Z. H. Qin, “Sestrin2 protects dopaminergic cells against rotenone toxicity through AMPK-dependent autophagy activation,” Molecular and Cellular Biology, vol. 35, no. 16, pp. 2740–2751, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. S. Chen, S. D. Chen, C. L. Wu, S. S. Huang, and D. I. Yang, “Induction of sestrin2 as an endogenous protective mechanism against amyloid beta-peptide neurotoxicity in primary cortical culture,” Experimental Neurology, vol. 253, pp. 63–71, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. A. A. Eid, D. Y. Lee, L. J. Roman, K. Khazim, and Y. Gorin, “Sestrin 2 and AMPK connect hyperglycemia to Nox4-dependent endothelial nitric oxide synthase uncoupling and matrix protein expression,” Molecular and Cellular Biology, vol. 33, no. 17, pp. 3439–3460, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S. H. Ro, X. Xue, S. K. Ramakrishnan et al., “Tumor suppressive role of sestrin2 during colitis and colon carcinogenesis,” eLife, vol. 5, article e12204, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. J. H. Lee, A. V. Budanov, S. Talukdar et al., “Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3,” Cell Metabolism, vol. 16, no. 3, pp. 311–321, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. H. Lee, A. V. Budanov, E. J. Park et al., “Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies,” Science, vol. 327, no. 5970, pp. 1223–1228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Chai, G. Wang, Z. Zhou, H. Yang, and Z. Yu, “Insulin increases Sestrin 2 content by reducing its degradation through the PI 3 K/mTOR signaling pathway,” International Journal of Endocrinology, vol. 2015, Article ID 505849, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. V. Nogueira, Y. Park, C. C. Chen et al., “Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis,” Cancer Cell, vol. 14, no. 6, pp. 458–470, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Hagenbuchner, A. Kuznetsov, M. Hermann, B. Hausott, P. Obexer, and M. J. Ausserlechner, “FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3,” Journal of Cell Science, vol. 125, no. Part 5, pp. 1191–1203, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Y. Shin, S. H. Jin, I. J. Cho, and S. H. Ki, “Nrf2-ARE pathway regulates induction of Sestrin-2 expression,” Free Radical Biology & Medicine, vol. 53, no. 4, pp. 834–841, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. S. J. Kim, K. M. Kim, J. H. Yang et al., “Sestrin2 protects against acetaminophen-induced liver injury,” Chemico-Biological Interactions, vol. 269, pp. 50–58, 2017. View at Publisher · View at Google Scholar
  30. B. Ding, A. Parmigiani, A. S. Divakaruni, K. Archer, A. N. Murphy, and A. V. Budanov, “Sestrin2 is induced by glucose starvation via the unfolded protein response and protects cells from non-canonical necroptotic cell death,” Scientific Reports, vol. 6, p. 22538, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. H. W. Park, H. Park, S. H. Ro et al., “Hepatoprotective role of Sestrin2 against chronic ER stress,” Nature Communications, vol. 5, p. 4233, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Bruning, M. Rahmeh, and K. Friese, “Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation,” Molecular Oncology, vol. 7, no. 6, pp. 1012–1018, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Saveljeva, P. Cleary, K. Mnich et al., “Endoplasmic reticulum stress-mediated induction of SESTRIN 2 potentiates cell survival,” Oncotarget, vol. 7, no. 11, pp. 12254–12266, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Olson, M. Hristova, N. H. Heintz, K. M. Lounsbury, and A. van der Vliet, “Activation of hypoxia-inducible factor-1 protects airway epithelium against oxidant-induced barrier dysfunction,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 301, no. 6, pp. L993–L1002, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Ben-Sahra, B. Dirat, K. Laurent et al., “Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death,” Cell Death and Differentiation, vol. 20, no. 4, pp. 611–619, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Essler, N. Dehne, and B. Brune, “Role of sestrin2 in peroxide signaling in macrophages,” FEBS Letters, vol. 583, no. 21, pp. 3531–3535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Laplante and D. M. Sabatini, “mTOR signaling in growth control and disease,” Cell, vol. 149, no. 2, pp. 274–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Zoncu, A. Efeyan, and D. M. Sabatini, “mTOR: from growth signal integration to cancer, diabetes and ageing,” Nature Reviews. Molecular Cell Biology, vol. 12, no. 1, pp. 21–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Hamatani, K. Hiromura, T. Sakairi et al., “Expression of a novel stress-inducible protein, sestrin 2, in rat glomerular parietal epithelial cells,” American Journal of Physiology. Renal Physiology, vol. 307, no. 6, pp. F708–F717, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Seo, S. Seo, S. H. Ki, and S. M. Shin, “Compound C increases Sestrin2 expression via mitochondria-dependent ROS production,” Biological & Pharmaceutical Bulletin, vol. 39, no. 5, pp. 799–806, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Shi, L. Xu, D. M. Doycheva, J. Tang, M. Yan, and J. H. Zhang, “Sestrin2, as a negative feedback regulator of mTOR, provides neuroprotection by activation AMPK phosphorylation in neonatal hypoxic-ischemic encephalopathy in rat pups,” Journal of Cerebral Blood Flow and Metabolism, vol. 37, no. 4, pp. 1447–1460, 2017. View at Publisher · View at Google Scholar
  42. P. Codogno and A. J. Meijer, “Autophagy and signaling: their role in cell survival and cell death,” Cell Death and Differentiation, vol. 12 Supplement 2, pp. 1509–1518, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Liu, X. Wen, and Y. Cheng, “Survival or death: disequilibrating the oncogenic and tumor suppressive autophagy in cancer,” Cell Death & Disease, vol. 4, article e892, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. K. H. Kim and M. S. Lee, “Autophagy—a key player in cellular and body metabolism,” Nature Reviews. Endocrinology, vol. 10, no. 6, pp. 322–337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Ishihara, M. Urushido, K. Hamada et al., “Sestrin-2 and BNIP3 regulate autophagy and mitophagy in renal tubular cells in acute kidney injury,” American Journal of Physiology. Renal Physiology, vol. 305, no. 4, pp. F495–F509, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Liang, J. Zhu, H. Huang et al., “SESN2/sestrin 2 induction-mediated autophagy and inhibitory effect of isorhapontigenin (ISO) on human bladder cancers,” Autophagy, vol. 12, no. 8, pp. 1229–1239, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. H. J. Hu, Z. Y. Shi, X. L. Lin, S. M. Chen, Q. Y. Wang, and S. Y. Tang, “Upregulation of Sestrin2 expression protects against macrophage apoptosis induced by oxidized low-density lipoprotein,” DNA and Cell Biology, vol. 34, no. 4, pp. 296–302, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Sciarretta, M. Volpe, and J. Sadoshima, “Mammalian target of rapamycin signaling in cardiac physiology and disease,” Circulation Research, vol. 114, no. 3, pp. 549–564, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Chen, X. Wang, M. Tong et al., “Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy,” PloS One, vol. 8, no. 5, article e64757, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. H. J. Hwang, T. W. Jung, J. H. Choi et al., “Knockdown of sestrin2 increases pro-inflammatory reactions and ER stress in the endothelium via an AMPK dependent mechanism,” Biochimica et Biophysica Acta, vol. 1863, no. 6, pp. 1436–1444, 2017. View at Publisher · View at Google Scholar
  51. S. H. Um, D. D'Alessio, and G. Thomas, “Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1,” Cell Metabolism, vol. 3, no. 6, pp. 393–402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. S. R. Kimball, B. S. Gordon, J. E. Moyer, M. D. Dennis, and L. S. Jefferson, “Leucine induced dephosphorylation of Sestrin2 promotes mTORC1 activation,” Cellular Signalling, vol. 28, no. 8, pp. 896–906, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. J. J. Howell, S. J. Ricoult, I. Ben-Sahra, and B. D. Manning, “A growing role for mTOR in promoting anabolic metabolism,” Biochemical Society Transactions, vol. 41, no. 4, pp. 906–912, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Zhou, C. Zhan, Q. Zhong, and S. Li, “Upregulation of sestrin-2 expression via P53 protects against 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity,” Journal of Molecular Neuroscience, vol. 51, no. 3, pp. 967–975, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Galanis, A. Pappa, A. Giannakakis, E. Lanitis, D. Dangaj, and R. Sandaltzopoulos, “Reactive oxygen species and HIF-1 signalling in cancer,” Cancer Letters, vol. 266, no. 1, pp. 12–20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Seo, S. H. Ki, E. Y. Park, and S. M. Shin, “5-Fluorouracil inhibits cell migration by induction of Sestrin2 in colon cancer cells,” Archives of Pharmacal Research, vol. 40, no. 2, pp. 231–239, 2017. View at Publisher · View at Google Scholar · View at Scopus